by admin | Apr 22, 2025 | News & Opinions
By News Medical Life Sciences – Bone regeneration continues to be a critical challenge in tissue engineering, with unpredictable outcomes often hindering clinical application. Current strategies overlook key factors such as donor differences and biological sex,...
by admin | Apr 21, 2025 | News & Opinions
by Kadeja Johnson – RegMedNet – 4basebio PLC has received a Good Manufacturing Practice certification from the UK Medicine and Healthcare Regulatory Agency (London), authorizing the company to supply GMP-grade synthetic DNA as both a starting material and...
by admin | Apr 18, 2025 | News & Opinions
By Smriti Mallapaty – Nature – Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might be around the corner. Japan is brimming with signs of an approaching medical revolution. Shiny white robots are...
by admin | Apr 17, 2025 | News & Opinions
By Ned Pagliarulo – PharmaVoice – A commission urged the U.S. government to prioritize biotechnology funding and policies to stay ahead of China in fields it argued are vital to national security. The U.S. risks losing a once-decisive edge over China in...
by admin | Apr 15, 2025 | News & Opinions
This is where the world’s top innovators, thought leaders, entrepreneurs, and investors come together to build a better world with synthetic biology. Join us in San Jose as we explore how synbio is transforming industries from healthcare, agriculture,...
